Tiger

Download
TigerAI
Help

Sino Biopharmaceutical Ltd.'s 2022Q2 financial report review

Aug13th Tuesday

Pre-market

Earnings Overview

Financial Data	Actual	YoY	Estimates
EPS	0.33	617.39%	0.11
Revenue	7.60B	6.84%	8.20B
EBIT	1.85B	-	1.50B

News

In-Depth Insights

The above content is machine - summarized based on the financial report. It is for reference only, does not constitute investment advice, and does not guarantee accuracy.

Market Insights

What's the highlight of Sino Biopharmaceutical Ltd.'s financial report?

Talk to TigerAI

Start

Exclusive Benefits

Analyst Forecast

Sino Biopharmaceutical Ltd.

USSBHMY

Mar20th Thursday

Pre-market

Analyst Price Targets

Data Last updated:

Analyst Recommendations

Relevant Information

Feedback

Welcome to share with us your comments or feedback

*T&Cs Apply. Capital at Risk, Not Investment Advice.

Learn more

Tiger

Mobile APP

APP STORE

GOOGLE PLAY

Desktop APP

Mac

macOS 10.13 or later

Windows

APP STORE

GOOGLE PLAY

Agreements and Declarations

Risk Disclosures

Terms and Conditions

cs@tigertrade.app

Regulated Entities

US TIGER SECURITIES, INC.

US Tiger Securities, Inc. is a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) (No.: 8-65324), member of the Financial Industry Regulatory Authority (FINRA) (CRD: 120583), member of the Securities Investor Protection Corporation (SIPC), and regulated by FINRA and SEC.

WEALTHN LLC

Wealthn LLC is a registered investment advisor with the SEC (No.: 801-114105) and regulated by the SEC.

TIGER BROKERS (AU) PTY LIMITED

Tiger Brokers (AU) Pty Limited, ABN 12 007 268 386, is licensed and regulated by Australian Securities and Investment Commission (ASIC), Australian Financial Services Licence no. 300767 (AFSL).

TIGER FINTECH (NZ) LIMITED

Tiger Fintech (NZ) Limited (NZCN: 8187510) is a client money and property service provider under the Financial Markets Conduct Act 2013. Tiger Fintech (NZ) Limited is not licensed by a New Zealand regulator to provide the client money and property service. Tiger Fintech (NZ) Limited's registration on the New Zealand register of financial service providers does not mean that Tiger Fintech (NZ) Limited is subject to active regulation or oversight by a New Zealand regulator.

TRADEUP SECURITIES, INC.

TradeUP Securities, Inc. is a licensed entity registered with the SEC (No.: 8-36754), member of the FINRA (CRD: 18483), member of the SIPC, member of the Depository Trust Company (DTC) and the National Securities Clearing Corporation (NSCC), and regulated by FINRA and SEC.

TIGER BROKERS (SINGAPORE) PTE. LTD.

Tiger Brokers (Singapore) Pte. Ltd. (Reg. No. 201810449W) is licensed and regulated by the Monetary Authority of Singapore and is authorised to operate in Singapore and for avoidance of doubt, is not authorised to operate in any other country. Tiger Brokers (Singapore) Pte. Ltd. does not solicit investors or market services in other jurisdictions such as China, Malaysia, and Vietnam. The content and materials published on this website is for information only and should not be regarded shall not be deemed as an offer, invitation, or solicitation, recommendation or advice to buy, sell, subscribe or dispose of any investment products, financial instruments or other financial services.

TIGER BROKERS (NZ) LIMITED

Tiger Brokers (NZ) Limited (NZCN: 5838590) is a client money and property service provider under the Financial Markets Conduct Act 2013. Tiger Brokers (NZ) Limited is not licensed by a New Zealand regulator to provide the client money and property service. Tiger Brokers (NZ) Limited's registration on the New Zealand register of financial service providers does not mean that Tiger Brokers (NZ) Limited is subject to active regulation or oversight by a New Zealand regulator.

TIGER BROKERS (HK) GLOBAL LIMITED

Tiger Brokers (HK) Global Limited (Central No. BMU940) is a licensed corporation of the Securities and Futures Commission of Hong Kong holding Type 1 ("Dealing in Securities"), Type 2 ("Dealing in Futures Contracts"), Type 4 ("Advising on Securities"), Type 5 ("Advising on Futures Contracts") and Type 9 (“Asset Management”) licenses.